Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jamil S, Syed"'
Autor:
Kamyar Ghabili, Nathan Paulson, Jamil S. Syed, Cayce B. Nawaf, Ghazal Khajir, Darryl T. Martin, John Onofrey, Michael S. Leapman, Angelique Levi, Jeffrey C. Weinreb, Peter A. Humphrey, Preston C. Sprenkle
Publikováno v:
Case Reports in Urology, Vol 2021 (2021)
The utility of serial Decipher biopsy scores in a true active surveillance population is still unknown. In a man on active surveillance for low-risk prostate cancer, a doubling of the Decipher biopsy score within genomic low-risk category from first
Externí odkaz:
https://doaj.org/article/38ad0f8f05204969b9ba9610e00aa9cb
Publikováno v:
Urology. 165:134-138
To assess the use of intraoperative IV ketorolac (Toradol) on the peri-operative total morphine milligram equivalent (MME) requirements of patients undergoing ureteroscopy for nephrolithiasis.Patients undergoing ambulatory ureteroscopy for nephrolith
Autor:
Syed N. Rahman, Soum D. Lokeshwar, Jamil S. Syed, Juan F. Javier-Desloges, Benjamin H. Press, Ankur U. Choksi, Pawel Rajwa, Benjamin Pradere, Guillaume Ploussard, Joseph W. Kim, Thomas F. Monaghan, Joseph R. Renzulli, Shahrokh F. Shariat, Michael S. Leapman
Publikováno v:
Urologic oncology.
There is lack of consensus about the effectiveness of neoadjuvant platinum-based chemotherapy in patients with micropapillary variant urothelial carcinoma (MVUC) prior to radical cystectomy. We studied the association between neoadjuvant chemotherapy
Publikováno v:
Current oncology reportsPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 24(2)
The use of genomic testing for prostate cancer continues to grow; however, utilization remains institutionally dependent. Herein, we review current tissue-based markers and comment on current use with active surveillance and prostate MRI.While data c
Autor:
Jamil S. Syed, Angela M. Arlen
Publikováno v:
The Journal of urology. 204(2)
Autor:
Jamil S, Syed, Kevin A, Nguyen, Alfie, Suarez-Sariemento, Cynthia, Leung, Marianne, Casilla-Lennon, Jay D, Raman, Brian, Shuch
Publikováno v:
The Canadian journal of urology. 26(2)
Approximately 7% of patients with localized upper tract urothelial cancer (UTUC) are treated without definitive therapy. Understanding outcomes and alternative therapy would aid in counseling older patients with comorbidities.We utilized the National
Autor:
Jamil S, Syed, Cayce B, Nawaf, James, Rosoff, Campbell, Bryson, Kevin A, Nguyen, Alfredo, Suarez-Sarmiento, Maria, Serrano, Adam S, Kibel, Peter, Humphrey, Brian, Shuch, Adebowale J, Adeniran
Publikováno v:
The Canadian journal of urology. 24(2)
Evidence has demonstrated that tumor size is related to adverse oncologic outcomes in small renal tumors (≤ 4 cm). We evaluated the association of adverse pathologic features (APF) with tumor size and survival in patients with a small renal mass (S
Autor:
Kevin A, Nguyen, Jamil S, Syed, Carin R, Espenschied, Holly, LaDuca, Ansh M, Bhagat, Alfredo, Suarez-Sarmiento, Timothy K, O'Rourke, Karina L, Brierley, Erin W, Hofstatter, Brian, Shuch
Publikováno v:
Cancer. 123(22)
Panel testing has been recently introduced to evaluate hereditary cancer; however, limited information is available regarding its use in kidney cancer.The authors retrospectively reviewed test results and clinical data from patients who underwent tar
Publikováno v:
Urology. 105:122